Form 4: New Enterprise Associates Converts Preferred Stock to Common Stock in Senti Biosciences

New Enterprise Associates 15, L.P. converted its Series A Convertible Preferred Stock into 3,333,000 shares of Common Stock in Senti Biosciences on March 10, 2025.

Summary

• On March 10, 2025, New Enterprise Associates 15, L.P. converted 3,333 shares of Series A Convertible Preferred Stock into 3,333,000 shares of Common Stock of Senti Biosciences, Inc.
• The conversion was triggered by Senti Biosciences exercising its right to automatically convert the preferred stock.
• Following the transaction, New Enterprise Associates 15, L.P. directly holds 3,775,615 shares of Common Stock.
• The filing also identifies NEA Partners 15, L.P., NEA 15 GP, LLC, Forest Baskett, Anthony Florence, Jr., Mohamad Makhzoumi, and Scott Sandell as indirect holders of the securities, but they disclaim beneficial ownership.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing related to a stock conversion, so the sentiment is neutral.

Industry Context

Form 4 filings are a routine part of the US stock market and are required by the SEC to provide transparency when corporate insiders and major shareholders transact in their company's stock. This filing indicates a conversion of preferred stock to common stock, which is a fairly common corporate action.

Stakeholder Impact

• The conversion of preferred stock to common stock could potentially dilute existing shareholders, but the impact is likely minimal given the size of the transaction relative to the overall market capitalization of Senti Biosciences.

Key Dates